BOSTON--(BUSINESS WIRE)--Nov. 13, 2014--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the company will present at the Jefferies 2014
Global Healthcare Conference on Wednesday, November 19, 2014 at 3:40
p.m. GMT in London.
A live webcast of the presentation can be accessed by visiting the
investors section of the Company’s website at www.verastem.com.
A replay will be archived on the Verastem website for 90 days following
the presentation date.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK,
PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.
Source: Verastem, Inc.
Verastem, Inc.
Brian Sullivan, 781-292-4212
bsullivan@verastem.com
